# US 2003/0228364 A1 · Amphiphilic polymers for medical applications

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0228364 A1
- Document ID: US20030228364A1
- Status: Published application
- Kind: A1
- Application number: 10/162,933
- Filed: 2002-06-05
- Published: 2003-12-11
- Earliest claimed: 2002-06-05
- Assignees: Ethicon, Inc.
- Inventors: Aruna Nathan
- Web page: https://patentgrep.com/patent/US20030228364A1

## CPC

- A61L 27/58: Materials at least partially resorbable by the body
- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/34: Macromolecular materials
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

The present invention is directed to medical devices or pharmaceutical compositions, each containing a synthetic, bioabsorbable, biocompatible polymer that is the reaction product of a polybasic acid or derivative thereof, a monoglyceride, and a polyether.

## Claims

### Claim 1

A medical device, comprising: a synthetic, bioabsorbable, biocompatible polymer comprising the reaction product of a polybasic acid or derivative thereof, a monoglyceride, and a polyether.

### Claim 2 (depends on 1)

The medical device of claim 1 wherein said polybasic acid or derivative thereof is selected from the group consisting of succinic acid, succinic anhydride, malic acid, tartaric acid, citric acid, diglycolic acid, diglycolic anhydride, glutaric acid, glutaric anhydride, adipic acid, pimelic acid, suberic acid, sebacic acid, fumaric acid, maleic acid, maleic anhydride, mixed anhydrides, esters, activated esters and acid halides.

### Claim 3 (depends on 1)

The medical device of claim 1 wherein said monoglyceride is selected from the group consisting of monostearoyl glycerol, monopalmitoyl glycerol, monomyrisitoyl glycerol, monocaproyl glycerol, monodecanoyl glycerol, monolauroyl glycerol, monolinoleoyl glycerol and monooleoyl glycerol.

### Claim 4 (depends on 3)

The medical device of claim 3 wherein said polybasic acid derivative is succinic anhydride.

### Claim 5 (depends on 3)

The medical device of claim 3 wherein said polybasic acid is succinic acid.

### Claim 6 (depends on 1)

The medical device of claim 1 wherein said polyether is selected from the group consisting of poly(ethylene oxide), poly(propylene oxide) and poly(tetra methylene oxide).

### Claim 7 (depends on 1)

The medical device of claim 1 wherein said polymer is branched.

### Claim 8 (depends on 1)

The medical device of claim 1 wherein said polymer comprises a copolymer.

### Claim 9 (depends on 8)

The medical device of claim 8 wherein said copolymer comprises the reaction product of said monoglyceride, said polyether, and at least two of said polybasic acids or derivatives thereof selected from the group consisting of succinic acid, succinic anhydride, malic acid, tartaric acid, citric acid, diglycolic acid and diglycolic anhydride.

### Claim 10 (depends on 8)

The medical device of claim 8 wherein said copolymer comprises the reaction product of said polybasic acid or derivative thereof, said polyether, and at least two monoglycerides selected from the group consisting of monostearoyl glycerol, monopalmitoyl glycerol, monomyrisitoyl glycerol, monocaproyl glycerol, monodecanoyl glycerol, monolauroyl glycerol, monolinoleoyl glycerol and monooleoyl glycerol.

### Claim 11 (depends on 8)

The medical device of claim 8 wherein said copolymer comprises the reaction product of said monoglyceride, said polybasic acid or derivative thereof, and at least two polyethers selected from the group consisting of poly(ethylene oxide), poly(propylene oxide) and poly(tetra methylene oxide).

### Claim 12 (depends on 1)

The medical device of claim 1 further comprising an effective amount of a bioactive agent.

### Claim 13 (depends on 1)

The medical device of claim 1 further comprising end capping moieties selected from the group consisting of alkyls, alkenyls, alkynyls, acrylates, methacrylates, amines, isocyanates and isothiocyanates.

### Claim 14 (depends on 1)

The medical device of claim 1 further comprising an aliphatic polyester prepared from monomers selected from the group consisting of glycolide, L-lactide, D-lactide, meso-lactide, rac-lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,4-dioxanone, 1,4-dioxepan-2-one, 1,5-dioxepan-2-one and substituted derivatives thereof.

### Claim 15 (depends on 1)

The medical device of claim 1 comprising a coating of said polymer.

### Claim 16 (depends on 15)

The medical device of claim 15 further comprising an aliphatic polyester prepared from the group of monomers selected from the group consisting of glycolide, L-lactide, D-lactide, meso-lactide, rac-lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,4-dioxanone, 1,4-dioxepan-2-one, 1,5-dioxepan-2-one and substituted derivatives thereof.

### Claim 17 (depends on 1)

The medical device of claim 1 comprising a bone replacement material comprising said polymer and an inorganic filler.

### Claim 18 (depends on 17)

The medical device of claim 17 wherein said inorganic filler is selected from the group consisting of alpha-tricalcium phosphate, beta-tricalcium phosphate, calcium carbonate, barium carbonate, calcium sulfate, barium sulfate and hydroxyapatite.

### Claim 19 (depends on 17)

The medical device of claim 17 wherein said inorganic filler comprises a polymorph of calcium phosphate.

### Claim 20 (depends on 17)

The medical device of claim 17 further comprising an effective amount of a bioactive agent.

### Claim 21 (depends on 1)

The medical device of claim 1 selected from the group consisting of sutures, stents, vascular grafts, stent-graft combinations, meshes, tissue engineering scaffolds, pins, clips, staples, films, sheets, foams, anchors, screws and plates.

### Claim 22

A composition, comprising: an effective amount of a bioactive agent, and a polymer comprising the reaction product of a polybasic acid or derivative thereof, a monoglyceride, and a polyether.

### Claim 23 (depends on 22)

The composition of claim 22 wherein said polybasic acid or derivative thereof is selected from the group consisting of succinic acid, succinic anhydride, malic acid, tartaric acid, citric acid, diglycolic acid, diglycolic anhydride, glutaric acid, glutaric anhydride, adipic acid, pimelic acid, suberic acid, sebacic acid and derivatives thereof.

### Claim 24 (depends on 22)

The composition of claim 22 wherein said monoglyceride is selected from the group consisting of monostearoyl glycerol, monopalmitoyl glycerol, monomyrisitoyl glycerol, monocaproyl glycerol, monodecanoyl, monolauroyl glycerol, monolinoleoyl glycerol and monooleoyl glycerol.

### Claim 25 (depends on 24)

The composition of claim 24 wherein said polybasic acid derivative is succinic anhydride.

### Claim 26 (depends on 24)

The composition of claim 24 wherein said polybasic acid is succinic acid.

### Claim 27 (depends on 22)

The composition of claim 22 wherein said polymeric wax is branched.

### Claim 28 (depends on 22)

The composition of claim 22 wherein said polymeric wax comprises a copolymer.

### Claim 29 (depends on 28)

The composition of claim 28 wherein said copolymer comprises the reaction product of said monoglyceride, said polyether, and at least two of said polybasic acids or derivatives thereof selected from the group consisting of succinic acid, succinic anhydride, malic acid, tartaric acid, citric acid, diglycolic acid and diglycolic anhydride.

### Claim 30 (depends on 28)

The composition of claim 28 wherein said copolymer comprises the reaction product of said polybasic acid or derivative thereof, said polyether, and at least two monoglycerides selected from the group consisting of monostearoyl glycerol, monopalmitoyl glycerol, monomyrisitoyl glycerol, monocaproyl glycerol, monodecanoyl glycerol, monolauroyl glycerol, monolinoleoyl glycerol and monooleoyl glycerol.

### Claim 31 (depends on 28)

The medical device of claim 28 wherein said copolymer comprises the reaction product of said monoglyceride, said polybasic acid or derivative thereof, and at least two polyethers selected from the group consisting of poly(ethylene oxide), poly(propylene oxide), and poly(tetra methylene oxide).

### Claim 32 (depends on 22)

The composition of claim 22 wherein said bioactive agent is selected from the group consisting of antiinfectives, analgesics, anorexics, antihelmintics, antiarthritics, antiasthmatics, anticonvulsants, antidepressants, antidiuretics, antidiarrheals, antihistamines, antiinflammatory agents, antimigraine preparations, antinauseants, antineoplastics, antiparkinsonism drugs, antipruritics, antipsychotics, antipyretics, antispasmodics, anticholinergics, sympathomimetics, xanthine derivatives, calcium channel blockers, beta-blockers, antiarrhythmics, antihypertensives, diuretics, vasodilators, central nervous system stimulants, decongestants, hormones, steroids, hypnotics, immunosuppressives, muscle relaxants, parasympatholytics, psychostimulants, sedatives, tranquilizers, naturally derived or genetically engineered proteins, growth factors, polysaccharides, glycoproteins, or lipoproteins, oligonucleotides, antibodies, antigens, cholinergics, chemotherapeutics, hemostatics, clot dissolving agents, radioactive agents and cystostatics.

### Claim 33 (depends on 22)

The composition of claim 22 further comprising an aliphatic polyester prepared from the group of monomers selected from the group consisting of glycolide, L-lactide, D-lactide, meso-lactide, rac-lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,4-dioxanone, 1,4-dioxepan-2-one, 1,5-dioxepan-2-one and substituted derivatives thereof.

### Claim 34 (depends on 1)

The device of claim 1 wherein said polymer is a polymeric wax having a melting point between about 25° C. and about 70° C.

### Claim 35 (depends on 1)

The device of claim 1 wherein said polymer is a liquid polymer having a melting point below about 25° C.

### Claim 36 (depends on 22)

The composition of claim 22 wherein said polymer is a polymeric wax having a melting point between about 25° C. and about 70° C.

### Claim 37 (depends on 22)

The device of claim 22 wherein said polymer is a liquid polymer having a melting point below about 25° C.

### Claim 38

A microdispersion comprising: a blend of a polymeric wax and a liquid polymer, wherein said polymeric wax and said liquid polymer comprise the reaction product of a polybasic acid or derivative thereof, a monoglyceride, and a polyether; wherein said polymeric wax has a melting point between about 25° C. and about 70° C., and wherein said liquid polymer has a melting point below about 25° C.

### Claim 39 (depends on 38)

The microdispersion of claim 38 wherein said polybasic acid or derivative thereof is selected from the group consisting of succinic acid, succinic anhydride, malic acid, tartaric acid, citric acid, diglycolic acid, diglycolic anhydride, glutaric acid, glutaric anhydride, adipic acid, pimelic acid, suberic acid, sebacic acid, fumaric acid, maleic acid, maleic anhydride, mixed anhydrides, esters, activated esters and acid halides.

### Claim 40 (depends on 38)

The microdispersion of claim 38 wherein said monoglyceride is selected from the group consisting of monostearoyl glycerol, monopalmitoyl glycerol, monomyrisitoyl glycerol, monocaproyl glycerol, monodecanoyl glycerol, monolauroyl glycerol, monolinoleoyl glycerol and monooleoyl glycerol.

### Claim 41 (depends on 40)

The microdispersion of claim 40 wherein said polybasic acid derivative is succinic anhydride.

### Claim 42 (depends on 40)

The microdispersion of claim 40 wherein said polybasic acid is succinic acid.

### Claim 43 (depends on 38)

The microdispersion of claim 38 wherein said polyether is selected from the group consisting of poly(ethylene oxide), poly(propylene oxide), and poly(tetra methylene oxide).

### Claim 44 (depends on 38)

The microdispersion of claim 38 further comprising an effective amount of a bioactive agent.
